切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2012, Vol. 01 ›› Issue (02) : 103 -108. doi: 10.3877/cma.j.issn.2095-3216.2012.02.009

论著

良性高血压肾小动脉硬化症患者的临床病理特点分析
寇佳1, 蔡广研1,(), 张雪光1, 吴杰1, 陈仆1, 刘述文1, 张岩1, 尹忠1, 师锁柱1, 陈香美1   
  1. 1.100853 北京,解放军总医院肾脏病科 全军肾脏病研究所 肾脏疾病国家重点实验室
  • 收稿日期:2012-06-20 出版日期:2012-12-18
  • 通信作者: 蔡广研

Clinical and pathological features of benign hypertensive nephrosclerosis

Jia KOU1, Guang-yan CAI1,(), Xue-guang ZHANG1, Jie WU1, Pu CHEN1, Shu-wen LIU1, Yan ZHANG1, Zhong YIN1, Suo-zhu SHI1, Xiang-mei CHEN1   

  1. 1.Department of Nephrology, Kidney Institute of Chinese People's Liberation Army, State Key Laboratory of Kidney Desease, Chinese People's Liberation Army General Hospital, Beijing 100853, China
  • Received:2012-06-20 Published:2012-12-18
  • Corresponding author: Guang-yan CAI
引用本文:

寇佳, 蔡广研, 张雪光, 吴杰, 陈仆, 刘述文, 张岩, 尹忠, 师锁柱, 陈香美. 良性高血压肾小动脉硬化症患者的临床病理特点分析[J/OL]. 中华肾病研究电子杂志, 2012, 01(02): 103-108.

Jia KOU, Guang-yan CAI, Xue-guang ZHANG, Jie WU, Pu CHEN, Shu-wen LIU, Yan ZHANG, Zhong YIN, Suo-zhu SHI, Xiang-mei CHEN. Clinical and pathological features of benign hypertensive nephrosclerosis[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2012, 01(02): 103-108.

目的

探讨良性高血压肾小动脉硬化症(BHN)患者的临床病理特点及血压对患者临床与病理检测指标的影响。

方法

回顾性分析1995年1月至2011年12月解放军总医院肾脏病科收治的48例经肾活检确诊的BHN患者临床资料,包括患者的年龄、血压以及实验室检查指标,病理资料采用半定量方法评价,分析肾小球病变、肾小管间质病变(包括间质炎细胞浸润、间质纤维化、肾小管萎缩)、肾小动脉病变(肾小动脉狭窄和肾小动脉透明变性)特点。采用Spearman等级相关分析法分析血压与临床病理指标的相关性,logistic回归法分析临床及病理改变的联系,多组间检测指标的比较采用单因素方差分析。

结果

BHN患者男女比例为3.8∶1.0,平均年龄(46.56±9.59)岁,入院时血压 > 140/90 mm Hg(1 mm Hg = 0.133 kPa)的患者33例(68.7%),尿蛋白定量< 1 g/24 h的患者26例(54.1%),估算的肾小球滤过率(eGFR) < 60 ml/(min . 1.73 m2)的患者24例(50.0%)。对全部肾小动脉进行分析,其中肌内膜肥厚狭窄肾小动脉100条(22.8%),透明变性肾小动脉89条(19.2%)。缺血性病变是肾小球病变最常见表现,共293个(32.9%),包括废弃性硬化180个(20.2%),缺血皱缩肾小球113个(12.7%)。收缩压与肌内膜肥厚狭窄肾小动脉数量(r = 0.35,P = 0.02)、肾小管间质病变程度(r = 0.295,P = 0.04)呈显著正相关,而与eGFR(r = - 0.333,P = 0.021)呈显著负相关;蛋白尿是导致球性硬化肾小球的独立影响因素(OR = 5.12,P = 0.04)。未发现代谢因素对肾脏病理改变的影响。

结论

BHN患者肾小球病变的最常见类型为缺血性病变;患者血压水平升高导致肌内膜肥厚狭窄肾小动脉数量增加,同时引起eGFR下降;蛋白尿是球性硬化肾小球增多的独立影响因素。控制血压、减少蛋白尿是防治高血压肾病的关键。

Objective

To analyze the clinical and pathological features of benign hypertensive nephrosclerosis (BHN), and to clarify the influence of blood pressure to clinical and pathological parameters on BHN.

Methods

Forty-eight patients diagnosesed as benign hypertensive nephrosclerosis proved by renal biopsy were retrospectively analyzed from 1995 to 2011 in our hospital. The clinical data included the age, blood presser and laboratory test indicators, and pathological data were measured by semi-quantitative, analyze the features of glomerular lesions, tubulointerstitial lesions (including interstitial inflammatory cell infiltration, interstitial fibrosis and tubular atrophy), and renal arterioles lesions (hyalinization, the endomysium hypertrophy). The features of renal arterioles, glomeruli and tubulointerstitial lesions were analyzed. Spearman rank correlation is used to analyze the correlation between the blood pressure and the clinical pathological data. Logistic regression is used to analyze the relationship between the clinical and pathological data. One-way ANOVA is used to compare differences among multi groups. SPSS17.0 software is used to take all statistical analysis. The correlation between blood pressure level and clinical or pathological parameters were analyzed.

Results

The ratio of male to female was 3.8∶1.0, and the average age was (46.56±9.59) years. Thirty-three patients (68.7%) showed blood pressure > 140/90 mm Hg(1 mm Hg = 0.133 kPa), and 26 (54.1%) disclosed urinary protein excretion < 1 g/24 h. 24 patients (50.0%) had eGFR < 60 ml/(min . 1.73 m2) at the time of admission.Number of myointimal hypertrophy arterioles was 100 (22.8%), and that of arterioles hyalinization was 84(19.2%). Ischemic lesions was the most common type of glomeruli damage, and the number is 293 (32.9%)including 180 obsolescent glomeruli (20.20%) and 113 ischemic wrinkled glomeruli (12.7%). Systolic blood pressure showed significant positive correlation with myointimal hypertrophy (r = 0.35, P = 0.02),tubulointerstitial lesion (r = 0.295, P = 0.04), but showed significant negative relation with eGFR (r =- 0.333, P = 0.021). Proteinuria was an independent influence factor for global sclerosis. Metabolic disorders had no influences on pathological changes.

Conclusions

Ischemic lesion was the most common type of glomerular damage. Percentage of myointimal hypertrophy increased and eGFR decreased as a result of hypertension, and proteinuria was an independent risk factor for global sclerosis. These results suggested that blood pressure control and reduction of proteinuria were the key for prevention and treatment of BHN.

表1 48例良性高血压肾小动脉硬化症患者的病理检测指标评分情况
表2 48例良性高血压肾小动脉硬化症患者的各项临床和病理检测指标比较
表3 48例良性高血压肾小动脉硬化症患者的各项检测指标与血压的相关性
1
Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy [J]. Hypertension, 2004, 44(5):595-601.
2
Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis [J]. Am J Kidney Dis, 1995,25(2): 207-221.
3
Johnson RJ, Rodríguez-Iturbe B, Schreiner GF, et al.Hypertension: a microvascular and tubulointerstitial disease [J]. J Hypertens Suppl, 2002, 20(3): S1-S7.
4
Tracy RE. Renal vasculature in essential hypertension: a review of some contrarian evidence [J]. Contrib Nephrol, 2011, 169: 327-336.
5
刘力生. 中国高血压防治指南2010 [J]. 中华高血压杂志, 2011,19(8): 701-708.
6
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009,150(9): 604-612.
7
Hill GS, Heudes D, Jacquot C, et al. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension [J]. Kidney Int, 2006, 69(5): 823-831.
8
Hill GS, Heudes D, Bariéty J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation [J]. Kidney Int, 2003, 63(3): 1027-1036.
9
邹万忠. 肾活检病理学[M]. 北京:北京大学医学出版社,2006.
10
Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease& end-stage renal disease in the United States [J]. Am J Kidney Dis, 2012, 59(1 Suppl 1): A7, e1-e420.
11
陈洪, 周春华. 2007年北京市新入血液透析患者病因组成分析[J]. 中国血液净化, 2009, 8(10): 567-570.
12
Kincaid-Smith P. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled‘hypertensive nephrosclerosis’ [J]. J Hypertens, 2004, 22(6): 1051-1055.
13
Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension [J].Am J Kidney Dis, 1994, 23(5): 655-660.
14
Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study.Atherosclerosis Risk in Communities Study [J]. Circulation,1995, 91(2): 284-290.
15
Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension,progressive renal disease, and uric acid: a pathogenetic link [J]. J Am Soc Nephrol, 2005, 16(7): 1909-1919.
16
Schainuck LI, Striker GE, Cutler RE, et al. Structural-functional correlations in renal disease. II. The correlations [J]. Hum Pathol,1970, 1(4): 631-641.
17
Striker GE, Schainuck LI, Cutler RE, et al. Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease [J]. Hum Pathol, 1970, 1(4): 615630.
18
Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis [J].Lancet, 1968, 2(7564): 363-366.
19
Yu F, Wu LH, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system [J]. Kidney Int, 2010, 77(9): 820-829.
20
D'Amico G. Tubulointerstitium as predictor of progression of glomerular diseases [J]. Nephron, 1999, 83(4): 289-295.
21
Cai GY, Chen XM. Immunoglobulin A nephropathy in China:progress and challenges [J]. Am J Nephrol, 2009, 30(3): 268-273.
[1] 曹雨欣, 毛卓君, 梁嘉赫, 伊江浦, 张泽凯, 马文帅, 陈云涛, 李晓倩, 张宇新, 曹铁生, 袁丽君. 3D打印心脏模型在模拟左心耳封堵术临床教学中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 602-607.
[2] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[3] 聂生军, 王钰, 王毅, 鲜小庆, 马生成. 复方倍他米松局部注射联合光动力疗法治疗小型瘢痕疙瘩的临床疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 404-410.
[4] 孙一娇, 包润发, 董平, 束翌俊. PBL结合手术视频剪辑教学在普通外科专科医师规范化培训中的应用与思考[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 96-99.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 张超, 张珍, 马梁, 穆欢欢, 刘彩玲. 腹腔镜胰十二指肠切除术术后C级胰瘘患者临床特征及影响因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 675-678.
[7] 任传富, 杨志, 徐恩, 何梓芸, 罗板鑫, 陈新, 夏雪峰. 腹腔镜疝修补术联合胃底折叠术治疗食管裂孔疝合并胃食管反流病40 例临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 507-511.
[8] 李义亮, 苏拉依曼·牙库甫, 麦麦提艾力·麦麦提明, 克力木·阿不都热依木. 机器人与腹腔镜食管裂孔疝修补术联合Nissen 胃底折叠术短期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 512-517.
[9] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 丁富贵, 吴泽涛, 董卫国. 家族性腺瘤性息肉病临床特征及生物信息学分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 512-518.
[12] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[13] 吴荣奎, 吴静, 冯俊浩, 钟嘉懿. 临床护理路径在经股动脉入路介入患者的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 729-733.
[14] 杨菲, 刘腾飞, 赵志军, 李睿聪, 张颉, 刘妍, 赵珍. 血清维生素水平与分化型甲状腺癌的关联性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 633-640.
[15] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
阅读次数
全文


摘要